Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)

Clinical trial NCT00799773 · TERMINATED

Trial details

NCT number: NCT00799773
Sponsor: Carelon Research
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombotic Thrombocytopenic Purpura

Start date: 2009-04-01
Primary completion: 2010-02-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.